The new I-Corps Northeast Hub, of which Rutgers, The State University of New Jersey is a key partner, announced its first researcher training program and is now accepting applications.
Startups & New Ventures
A Rutgers professor’s novel research into targeting and silencing defective, disease-causing RNA molecules has led to the launch of Ceptur Therapeutics, a startup that has raised $75 million in Series A funding.
Stories
Asthma and allergies are chronic health conditions that continue to adversely impact the quality of life for many around the world. Thanks to exciting breakthroughs by Mark Siracusa, a researcher at Rutgers, The State University of New Jersey, there may be early signs of light at the end of the tunnel.
A group of former Rutgers students who developed a pacifier-like device that delivers medication and nutrients to malnourished infants are working to see their project put to use for the first time at a major hospital system.
It’s been a record year for innovation at Rutgers University, and for the Innovation Ventures team in the Office for Research, despite the challenges and new reality that came with the COVID-19 pandemic. Even limited access to laboratories, countless Zoom meetings, and the burnout many experienced over the past year could not stop the Rutgers Research and Innovation engine.
As a key player in developing and transforming innovators into entrepreneurs that improve people’s lives, Rutgers, The State University of New Jersey will expand its entrepreneurship training programming and further equip faculty and student researchers with the skills and strategy needed to transition their discoveries into technologies and products, as a partner in the newly created NSF I-Corps™ Hub: Northeast Region.
A company founded by Rutgers School of Dental Medicine researcher received U.S. Food and Drug Administration approval to begin a phase I clinical trial to treat cancer patients with a therapy based on his discovery that a protein produced by an oral bacterium can kill leukemia and lymphoma cells.